U.S. RESEARCH ROUNDUP-Everpure, Marvell Technology, Okta
U.S. RESEARCH ROUNDUP-Everpure, Marvell Technology, Okta Aug 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Everpure, Marvell Technology and Okta, on Tuesday.
HIGHLIGHTS
* Abercrombie & Fitch Co. ANF.N: JP Morgan raises target price to $126 from $110 |
* Everpure Inc P.N: TD Cowen raises target price to $170 from $100 |
* Marvell Technology, Inc. MRVL.O: TD Cowen raises target price to $225 from $200 |
* Okta Inc OKTA.O: Jefferies raises target price to $170 from $140 |
* Urban Outfitters Inc URBN.O: JP Morgan raises target price to $110 from $97 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Abercrombie & Fitch Co. ANF.N: JP Morgan raises target price to $126 from $110 |
* Abercrombie & Fitch Co. ANF.N: Raymond James cuts to market perform from outperform |
* Acadia Realty Trust AKR.N: KeyBanc raises to overweight from sector weight |
* Amgen Inc AMGN.O: Mizuho raises target price to $352 from $303 |
* Amylyx Pharmaceuticals Inc AMLX.O: H.C. Wainwright raises target price to $55 from $34 |
* Applied Materials Inc AMAT.O: Argus Research raises target price to $600 from $500 |
* Ataibeckley Inc ATAI.O: Oppenheimer cuts to perform from outperform |
* Bath & Body Works Inc BBWI.N: Citigroup raises to buy from neutral |
* Biomarin Pharmaceutical Inc. BMRN.O: H.C. Wainwright cuts target price to $59 from $60 |
* Campbell'S Co CPB.O: JP Morgan raises target price to $22 from $20 |
* Cheniere Energy Inc LNG.N: Argus Research raises target price to $330 from $284 |
* Chime Financial Inc CHYM.O: Morgan Stanley raises target price to $39.00 from $33.00 |
* Choice Hotels International Inc CHH.N: Morgan Stanley raises target to $91.00 from $86.00 |
* Ciena Corporation CIEN.N: TD Cowen cuts target price to $575 from $675 |
* Corcept Therapeutics Incorporated CORT.O: Truist Securities assumes with buy rating |
* Corcept Therapeutics Incorporated CORT.O: Truist Securities assumes with PT $164 vs $50 |
* Corteva, Inc. CTVA.N: UBS cuts target price to $85 from $89 |
* Crowdstrike CRWD.O: Benchmark raises target price to $250 from $230 |
* Diamondrock Hospitality Co DRH.O: Morgan Stanley raises target price to $11.00 from $10.00 |
* Duolingo, Inc. DUOL.O: D.A. Davidson raises to buy from neutral; raises PT to $160 |
* Enliven Therapeutics, Inc. ELVN.O: Mizuho raises target price to $73 from $62 |
* Enliven Therapeutics, Inc. ELVN.O: William Blair initiates coverage with outperform rating |
* Essex Property Trust ESS.N: Deutsche Bank cuts target price to $325 from $330 |
* Ethos Technologies Inc LIFE.O: JP Morgan raises target price to $37 from $23 |
* Everpure Inc P.N: TD Cowen raises target price to $170 from $100 |
* Eyepoint Inc EYPT.O: Citigroup cuts target price to $17 from $35 |
* Eyepoint Inc EYPT.O: H.C. Wainwright cuts to neutral from buy |
* Eyepoint Inc EYPT.O: Jefferies cuts target price to $8 from $30 |
* Eyepoint Inc EYPT.O: JP Morgan cuts to neutral from overweight |
* Eyepoint Inc EYPT.O: RBC cuts to sector perform from outperform; cuts PT to $5 from $37 |
* Ferguson Enterprises FERG.N: BofA Global Research cuts price objective to $315 from $325 |
* Ferguson Enterprises Inc FERG.N: Deutsche Bank raises target price to $261 from $256 |
* First Solar Inc FSLR.O: Morgan Stanley raises target price to $323.00 from $245.00 |
* First Tracks Biotherapeutics Inc TRAX.O: JP Morgan raises target price to $65 from $30 |
* Flutter Entertainment Plc FLUT.N: Goldman Sachs cuts target price to $162 from $190 |
* Freenome, Inc. FRNM.O: TD Cowen initiates coverage with buy rating; price target $17 |
* Gartner IT.N: BMO cuts target price to $206 from $214 |
* Haemonetics Corp HAE.N: BofA Global Research raises price objective to $120 from $100 |
* Haemonetics Corp HAE.N: BTIG raises target price to $110 from $96 |
* Hilton Grand Vacations Inc HGV.N: Morgan Stanley cuts target price to $54.00 from $58.00 |
* Hyatt Hotels Corporation H.N: Morgan Stanley cuts target price to $209.00 from $218.00 |
* Inc WH.N: Morgan Stanley cuts target price to $91.00 from $93.00 |
* Intensity Therapeutics, Inc. INTS.O: H.C. Wainwright raises target price to $7 from $5 |
* Kite Realty Group Trust KRG.N: KeyBanc cuts to sector weight from overweight |
* L3Harris Technologies, Inc. LHX.N: Deutsche Bank cuts target price to $269 from $285 |
* Lantheus Holdings, Inc. LNTH.O: B. Riley cuts target price to $105.4 from $129 |
* Lantheus Holdings, Inc. LNTH.O: B. Riley cuts to neutral from buy |
* Life Time Group Holdings, Inc LTH.N: Morgan Stanley raises target price to $53 from $39 |
* Marriott Vacations Worldwide Corp VAC.N: Morgan Stanley raises target to $65 from $52 |
* Marvell Technology, Inc. MRVL.O: TD Cowen raises target price to $225 from $200 |
* Mongodb, Inc. MDB.O: Stifel raises target price to $475 from $435 |
* NetApp Inc NTAP.O: Citigroup raises target price to $209 from $150 |
* Norwegian Cruise Line NCLH.N: Mizuho cuts target price to $17 from $22 |
* Norwegian Cruise Line NCLH.N: Mizuho cuts to neutral from outperform |
* Norwegian Cruise Line Holdings Ltd NCLH.N: UBS raises target price to $20 from $17 |
* Nuvation Bio Inc. NUVB.N: JP Morgan initiates coverage with overweight rating; PT $13 |
* Okta, Inc. OKTA.O: Jefferies raises target price to $170 from $140 |
* Quince Therapeutics QNCX.O: Leerink Partners adjusts PT to $68 from $4 to reflect 1-for-20 reverse stock split |
* Sailpoint Inc SAIL.O: BofA Global Research raises price objective to $19 from $16 |
* Salesforce, Inc. CRM.N: Citigroup raises target price to $204 from $187 |
* Scribe Therapeutics Inc SCTX.O: Leerink Partners initiates with outperform rating |
* Scribe Therapeutics Inc SCTX.O: Leerink Partners initiates with price target $37 |
* Sentinelone Inc S.N: BofA Global Research raises price objective to $26 from $22 |
* Sharplink SBET.O: Canaccord Genuity cuts target price to $8 from $16 |
* Smartfinancial Inc SMBK.N: Benchmark raises target price to $60 from $56 |
* Snowflake Inc SNOW.N: UBS raises target price to $425 from $370 |
* Snowflake Inc. SNOW.N: Stifel raises target price to $350 from $300 |
* Sunshine Silver Mining & Refining Co SSMR.N: Canaccord Genuity initiates with PT $20 |
* Sunshine Silver Mining & Refining Co SSMR.N: Canaccord Genuity initiates with speculative buy rating |
* Tango Therapeutics Inc TNGX.O: H.C. Wainwright raises target price to $68 from $66 |
* Targa Resources Corp TRGP.N: Jefferies raises target price to $345 from $324 |
* Target Hospitality Corp TH.O: Morgan Stanley initiates coverage with overweight rating |
* Target Hospitality Corp TH.O: Morgan Stanley initiates coverage with price target $22 |
* The New York Times Company NYT.N: Deutsche Bank cuts target price to $75 from $95 |
* Travel & Leisure Co TNL.N: Morgan Stanley raises target price to $85.00 from $83.00 |
* Urban Outfitters Inc URBN.O: JP Morgan raises target price to $110 from $97 |
* Victoria'S Secret & Co VSXY.N: UBS raises target price to $95 from $90 |
* Waterbridge Infrastructure Llc WBI.N: JP Morgan resumes coverage with overweight rating |
* Waterbridge Infrastructure Llc WBI.N: JP Morgan resumes coverage with target price $38 |
* Weave Communications Inc WEAV.N: B. Riley initiates coverage with buy rating; PT $8.25 |
* Weave Communications Inc WEAV.N: Piper Sandler cuts target price to $7.4 from $8 |
* Weave Communications Inc WEAV.N: Piper Sandler cuts to neutral from overweight |
* Xerox Holdings Corp XRX.O: Northland Capital initiates coverage with outperform rating |
* Xerox Holdings Corp XRX.O: Northland Capital initiates coverage with target price $5 |
* York Space Systems Inc YSS.N: Canaccord Genuity cuts target price to $13.5 from $36 |
* York Space Systems Inc YSS.N: Canaccord Genuity cuts to hold from buy |
* York Space Systems Inc YSS.N: Jefferies cuts target price to $15 from $32 |
* Zscaler Inc ZS.O: BofA Global Research raises price objective to $210 from $175 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Recent news on Abercrombie & Fitch
See all newsAmerican Eagle shares slump on flat margin outlook, weakness in namesake brand (updated)
American Eagle shares slide as flat margin outlook, weak core brand weigh
American Eagle sticks to annual sales forecast again, shares slump (updated)
American Eagle Outfitters beats quarterly revenue estimates
U.S. RESEARCH ROUNDUP-CrowdStrike, Nvidia, Macerich